CDK4/6 inhibitors in breast cancer
Participant's evaluation form
Read time: 5 mins
Last updated:22nd Jul 2022
Published:22nd Jul 2022
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Eli Lilly, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.